Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > My calculations add up to more than current sp !

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison Sep 03, 2023 9:49am

184 Views

Post# 35617954

RE:My calculations add up to more than current sp !

Oden6570 wrote: Intellectual Property 46 issued patents for PDC and laser technology in the United States, Canada and internationally1 Composition of matter patent expires in US in 2033 (Potentially 2038 with extension) 23 patents pending

Theralase-Corporate-Presentation-05-18-2023.pdf

Good read Oden6570, my concern with overall numbers quoted in this report didn't differentiate out of their North American (91,000) or World (573,000) numbers that 75% are NMIBC and 25% are MIBC. Am I to assume that perhaps MIBC will also be treatable by Theralase?

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages